Anyway, the remarkable metabolic flexibility and reprogramming of melanoma cells account for the impressive aggressiveness of CM and can also sustain resistance response to BRAF/MEK inhibitors (BRAFi/MEKi) and immunotherapy (2, 6). This evidence concerns the gene BRAF and melanoma.